Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan;106(1-2):11-8, quiz 19.
doi: 10.3238/arztebl.2009.0011. Epub 2009 Jan 5.

Psoriasis--new insights into pathogenesis and treatment

Ulrich Mrowietz  1 , Kristian Reich
Affiliations
Review

Psoriasis--new insights into pathogenesis and treatment

Ulrich Mrowietz et al. Dtsch Arztebl Int. 2009 Jan.

Abstract

Background: Psoriasis is one of the most prevalent chronic inflammatory diseases, affecting approximately 2 million people in Germany.

Methods: Selective literature review taking into account the German S1 and S3 guidelines for the treatment of this condition.

Results and conclusions: Psoriasis is a very troublesome disease with a high economic impact. The disease often persists for life, and the patient has an increased risk of cardiovascular diseases and their complications. One out of five patients develops psoriatic arthritis. The clinical picture of psoriasis is highly variable with regard to lesional characteristics and the severity of disease. To improve the management of psoriasis the guidelines must be followed and all appropriate topical and systemic treatment options must be tried, with clearly defined treatment goals. The spectrum of established systemic treatments for psoriasis has been extended by the biologics. These can be used to achieve a good skin status and a clear-cut improvement in quality of life even in patients who do not--or no longer--respond adequately to conventional therapies.

Keywords: genetics; guidelines; immune-mediated inflammatory disease; psoriasis; treatment concept.

PubMed Disclaimer

Figures

Figure
Figure
Clinical types of psoriasis:
See this image and copyright information in PMC

References

    1. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13:450–456. - PubMed
    1. Reich K, Hüffmeier U, König IR, et al. TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-875 independent of the PSORS1 risk allele. Arthritis Rheum. 2007;56:2056–2064. - PubMed
    1. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80:273–290. - PMC - PubMed
    1. Diluvio L, Vollmer S, Besgen P, Ellwart JW, Chimenti S, Prinz JC. Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. J Immunol. 2006;176:7104–7111. - PubMed
    1. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol. 2007;25:606–615. - PubMed